Add BrightSurf on Google Email

Johns Hopkins Medicine


Super-effective 'jumping gene' created

Researchers at Johns Hopkins Medicine have created an artificial jumping gene that can randomly silence genes in mice, offering a new way to study genetic function and evolution. The discovery has the potential to reveal how genes interact with each other and contribute to human health and disease.

SourceJohns Hopkins Medicine·JournalNature·DateMay 19, 2004

Stem cells toward sperm cells and back again

Scientists at Johns Hopkins Medicine have discovered that lost sperm-making stem cells in fruit flies can be replaced by reversing their specialized state. The team found that temperature changes can trigger a process called dedifferentiation, where more specialized cells retrace the path taken by stem cells.

SourceJohns Hopkins Medicine·JournalScience·DateMay 18, 2004

Oxygen therapy may improve vision worsened by diabetes

A study published in Investigative Ophthalmology & Visual Science found that breathing supplemental oxygen for three months reduced fluid buildup and swelling in the macula, and improved visual acuity in some cases. The therapy was found to reduce excess thickness of the macula by an average of 43 percent.

SourceJohns Hopkins Medicine·JournalInvestigative Ophthalmology & Visual Science·DateMay 17, 2004

Patients happy with robo-doc

A study found that robotic doctor visits increased patient comfort and accessibility to medical information, with 57% suggesting it should become a standard practice. Patients preferred having their own physician conduct telerounds over others.

Study: New neurons can get out of spinal cord

Researchers at Johns Hopkins Medicine have successfully coaxed new motor neurons out of embryonic stem cells and into the spinal cords of paralyzed rats. The study, funded by various organizations, aims to overcome a major hurdle in clinical therapy for motor neuron diseases like ALS and SMA.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateApr 27, 2004

Hopkins scientists overcome main obstacle to making tons of short, drug-like proteins

Scientists at Johns Hopkins Medicine have overcome a major obstacle to creating large libraries of drug-like peptides. By modifying naturally occurring amino acids with a methyl group, they can produce up to 10 billion stabilized peptides in a single reaction. This breakthrough enables the rapid testing of potential medicines and has s...

SourceJohns Hopkins Medicine·JournalChemistry & Biology·DateApr 22, 2004

Crowding stem cells' personal space directs their future

Researchers at Johns Hopkins Medicine found that mesenchymal stem cell shape is a critical factor in determining which type of cell they will become. By using micropatterning technology, the team showed that spherical stem cells efficiently transform into fat cell precursors, while those allowed to stretch and flatten move closer to be...

SourceJohns Hopkins Medicine·JournalDevelopmental Cell·DateApr 16, 2004

Gaining health while giving back to the community

The study found that Experience Corps volunteers experienced increased physical, cognitive, and social activity, which could lead to improved health outcomes. Volunteers also reported feeling stronger and had a reduced need for canes. In contrast, the control group showed a decline in social activity and an increase in TV viewing.

SourceJohns Hopkins Medicine·JournalJournal of Urban Health·DateApr 6, 2004

Genetic mutation linked to infant lung disease

A genetic mutation in the ABCA3 gene is linked to severe surfactant deficiency in infants, leading to fatal lung disease. Researchers found mutations in 16 infants, with 15 dying from their illness, and discovered a potential mechanism for the defective transport of phospholipids critical for surfactant function.

SourceJohns Hopkins Medicine·JournalNew England Journal of Medicine·DateMar 24, 2004

Combination of toxin and poison may be novel treatment for leukemia

Scientists at Johns Hopkins Medicine have found that a low-dose combination of arsenic and bryostatin can kill APL cell lines by activating the cancer cells' natural self-destruct mechanism. This therapy has potential for treating treatment-resistant acute promyelocytic leukemia, a subtype of acute myeloid leukemia with poor outcomes.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateMar 15, 2004

Hopkins researchers find MRI useful tool in diagnosing inflammatory bowel diseases in children

A study published in Inflammatory Bowel Diseases found that gadolinium-enhanced MRI (G-MRI) was highly accurate in diagnosing inflammatory bowel disease (IBD) in children, with 92% accuracy for ulcerative colitis and 96% accuracy for Crohn's disease. This non-invasive diagnostic tool could replace conventional tests like colonoscopy.

SourceJohns Hopkins Medicine·JournalInflammatory Bowel Diseases·DateMar 4, 2004

Patients give nod to kidney dialysis at home

A study by Johns Hopkins researchers found that patients on peritoneal dialysis rate their care as excellent, citing independence, access to staff, and quality of treatment. In contrast, hemodialysis patients report lower satisfaction rates, with many citing inadequate information and economic factors as barriers.

SourceJohns Hopkins Medicine·JournalJAMA·DateFeb 10, 2004

Inflammation marker predicts colon cancer

A study published in The Journal of the American Medical Association found that people with higher CRP levels were more likely to develop colorectal cancers over an 11-year period. Median CRP levels were higher among those who developed colon cancer, and inflammation was linked to increased risk without being mediated by diabetes.

SourceJohns Hopkins Medicine·JournalJAMA·DateFeb 3, 2004

'HapMap' scientists provide detailed plans

The HapMap project aims to create a catalog of common genetic patterns, or haplotypes, which will simplify and accelerate efforts to identify genes associated with chronic diseases. By analyzing DNA samples from over 270 individuals from four countries, the project hopes to provide insights into human genetics.

SourceJohns Hopkins Medicine·JournalNature·DateDec 18, 2003

Key appetite regulator may be identified, scientists report

Researchers at Johns Hopkins Medicine have identified malonyl-CoA as a key chemical regulator of appetite in mice. By injecting the compound C75 into the brain, they found that levels of malonyl-CoA increase immediately after feeding, triggering appetite signals. This breakthrough understanding could lead to new ways to control appetite.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateDec 18, 2003